Changes in Visual Acuity in a Population Over a 15-year Period: The Beaver Dam Eye Study - 18/08/11
, Barbara E.K. Klein, MD, MPH a, Kristine E. Lee, MS a, Karen J. Cruickshanks, PhD a, b, Ronald E. Gangnon, PhD b
Inquiries to Ronald Klein, MD, MPH, Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, 610 North Walnut Street, 417 WARF, Madison, WI 53726-2336;Résumé |
Purpose |
To describe the change in visual acuity in a 15-year period.
Design |
Population-based study.
Methods |
setting: Beaver Dam, Wisconsin. participants: 4068 persons 43 to 86 years of age at the time of a baseline examination in 1988 to 1990, and with follow-up examinations every five years thereafter. observation procedures: Best-corrected visual acuity after refraction, assessed by a modification of the ETDRS protocol. main outcome measure: Doubling of the visual angle; incidence of visual impairment.
Results |
Eight percent of the population developed impaired vision (20/40 or worse), 0.8% developed severe visual impairment (20/200 or worse), 7% had doubling of the visual angle, and 2% had improved vision. People 75 years of age or older at baseline were more likely to develop impaired vision (odds ratio [OR] 12.8, 95% confidence interval [CI] 9.6 to 17.1, P < .001), doubling of the visual angle (OR 7.8, 95% CI 5.6 to 10.7, P < .001), and severe visual impairment (OR 20.6, 95% CI 9.5 to 44.8, P<0.001) compared with people younger than 75 years of age.
Conclusions |
These data provide population-based estimates of the cumulative 15-year incidence of loss of vision over a wide spectrum of ages. In people 75 years of age or older the cumulative incidence of visual impairment accounting for the competing risk of death is 25%, of which 4% is severe, indicating a public health problem of considerable proportions as the US population in this age is expected to increase by 55% from 18 million in the year 2005 to 28 million by the year 2025.
Le texte complet de cet article est disponible en PDF.Plan
| Supported in part by National Institutes of Health Grant EY06594 (R.K., B.E.K.K.), and, in part, by Research to Prevent Blindness (R.K., B.E.K.K., Senior Scientific Investigator Award), New York, New York. |
Vol 142 - N° 4
P. 539 - octobre 2006 Retour au numéro
Article précédent
- Editorial board
- Effect of Topical Prednisolone and Diclofenac on the Short-Term Change in Morphology of Posterior Capsular Opacification
- Thomas Neumayer, Wolf Buehl, Oliver Findl
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?